financetom
Business
financetom
/
Business
/
Warner Bros Discovery amends CEO Zaslav's contract amid strategic review
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Warner Bros Discovery amends CEO Zaslav's contract amid strategic review
Nov 13, 2025 3:13 PM

(Reuters) -Warner Bros Discovery said on Thursday it has amended CEO David Zaslav's employment agreement as the entertainment company undertakes a strategic review of its business.

As part of this process, Zaslav has agreed to amend his tenure and nonqualified stock option agreements, originally entered in June.

The company said it would extend Zaslav's agreement to December 2030, if there is a "change in control", but excluding any sale of Discovery Global or all or substantially all of its assets.

Warner Bros Discovery has been considering a range of options including a planned separation, a deal for the entire company, or separate transactions for its Warner Bros or Discovery Global businesses, the company had said in October.

The initial deadline to submit non-binding first-round bids is November 20, a source close to the matter said.

Reuters has reported that Comcast, Paramount Skydance and Netflix have explored bids for the whole of Warner Bros Discovery or in parts.

Shares of the company were up 3% after the bell.

(Reporting by Juby Babu in Mexico City; Editing by Shilpi Majumdar and Sriraj Kalluvila)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alzheimer's-Focused Small Cap Firm IGC Pharma Releases Data,  Candidate Reduces Agitation Compared To Placebo
Alzheimer's-Focused Small Cap Firm IGC Pharma Releases Data, Candidate Reduces Agitation Compared To Placebo
Mar 20, 2024
Wednesday, IGC Pharma Inc ( IGC ) announced the results of an interim analysis of its ongoing Phase 2 trial of IGC-AD1 for Agitation in Dementia from Alzheimer’s Disease (AAD). The interim data demonstrates a clinical and statistically significant reduction in agitation compared to placebo in patients with Alzheimer’s disease. The study’s primary goal is to assess the change in AAD after six...
Hilton Worldwide to Remain Resilient in a Recession, Macquarie Says
Hilton Worldwide to Remain Resilient in a Recession, Macquarie Says
Mar 20, 2024
01:20 PM EDT, 03/20/2024 (MT Newswires) -- Hilton Worldwide Holdings ( HLT ) will remain resilient in a recession as franchised hotels drive 80% of fees, Macquarie Equity Research said in a note. We believe investors will continue to view positively the consistent fee growth, [6% to 7% net unit growth] outlook and capital returns story, Macquarie said. The firm...
Sector Update: Consumer
Sector Update: Consumer
Mar 20, 2024
01:32 PM EDT, 03/20/2024 (MT Newswires) -- Consumer stocks were mixed Wednesday afternoon with the Consumer Staples Select Sector SPDR Fund (XLP) little changed and the Consumer Discretionary Select Sector SPDR Fund (XLY) up 0.3%. In corporate news, Signet Jewelers' ( SIG ) fiscal Q4 sales declined from a year earlier, missing market estimates, and the company issued a downbeat...
Quantum eMotion Completes Private Placement; Up 4.5%
Quantum eMotion Completes Private Placement; Up 4.5%
Mar 20, 2024
01:29 PM EDT, 03/20/2024 (MT Newswires) -- Quantum eMotion Corp. ( QNCCF ) said Wednesday that it has closed a non-brokered private placement. The company issued 15 million units at $0.05 apiece. The company has raised gross proceeds of $750,000. This includes the participation of several strategic investors. Each unit is comprised of one common share and one warrant of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved